chrX-1305655-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000381509.8(CSF2RA):​c.1153G>A​(p.Gly385Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 1,606,370 control chromosomes in the GnomAD database, including 105 homozygotes. There are 1,882 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 63 hom., 1008 hem., cov: 32)
Exomes 𝑓: 0.0014 ( 42 hom. 874 hem. )

Consequence

CSF2RA
ENST00000381509.8 missense

Scores

1
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.27

Publications

0 publications found
Variant links:
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]
CSF2RA Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary pulmonary alveolar proteinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024722815).
BP6
Variant X-1305655-G-A is Benign according to our data. Variant chrX-1305655-G-A is described in ClinVar as Benign. ClinVar VariationId is 178718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0505 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RANM_172245.4 linkc.1125+128G>A intron_variant Intron 12 of 12 ENST00000381529.9 NP_758448.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RAENST00000381529.9 linkc.1125+128G>A intron_variant Intron 12 of 12 1 NM_172245.4 ENSP00000370940.3

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2133
AN:
152158
Hom.:
62
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00345
AC:
799
AN:
231596
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.0530
Gnomad AMR exome
AF:
0.00107
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000389
Gnomad OTH exome
AF:
0.00120
GnomAD4 exome
AF:
0.00138
AC:
2008
AN:
1454094
Hom.:
42
Cov.:
32
AF XY:
0.00121
AC XY:
874
AN XY:
722820
show subpopulations
African (AFR)
AF:
0.0526
AC:
1750
AN:
33270
American (AMR)
AF:
0.00106
AC:
45
AN:
42578
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25942
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39430
South Asian (SAS)
AF:
0.0000466
AC:
4
AN:
85826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53056
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000199
AC:
22
AN:
1108088
Other (OTH)
AF:
0.00301
AC:
181
AN:
60154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
122
244
367
489
611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2139
AN:
152276
Hom.:
63
Cov.:
32
AF XY:
0.0135
AC XY:
1008
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0500
AC:
2078
AN:
41558
American (AMR)
AF:
0.00229
AC:
35
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68020
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
94
189
283
378
472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Bravo
AF:
0.0161
ESP6500AA
AF:
0.0549
AC:
76
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00448
AC:
542

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly385Ser in exon 13B of CSF2RA: This variant is not expected to have clinical s ignificance because it has been identified in 5.5% (76/1384) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs147124116). -

not provided Benign:1
Oct 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
3.5
DANN
Uncertain
0.99
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.29
T
PhyloP100
1.3
PROVEAN
Benign
0.44
N
REVEL
Benign
0.18
Sift
Benign
0.57
T
Sift4G
Benign
0.54
T
Polyphen
1.0
D
Vest4
0.083
MVP
0.42
ClinPred
0.0055
T
GERP RS
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147124116; hg19: chrX-1424548; API